Name | 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine |
---|---|
Synonyms |
Mebron
Epirizolum [INN-Latin] Mepirizole Mepirizol [German] 4-methoxy-2-(5-methoxy-3-methyl-pyrazol-1-yl)-6-methyl-pyrimidine 1-(4-Methyl-6-methoxy-pyrimidin-2-yl)-3-methyl-5-methoxy-pyrazol DA-398 Methopyrimazole 4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine Epirizol [INN-Spanish] EINECS 242-507-1 epirizole MFCD00057351 1-(4-Methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxy-pyrazol |
Description | Epirizole (Mepirizole) is an orally active NSAID (nonsteroidal anti-inflammatory drug). Epirizole shows anti-inflammatory activity, and can be used in chronic rheumatoid arthritis research[1]. |
---|---|
Related Catalog | |
In Vitro | Epirizole (1-1000 μM; 24 h) increases MDR1 mRNA expression in Caco-2 cells[1]. RT-PCR[1] Cell Line: Caco-2 cells Concentration: 1, 10, 100, and 1000 μM Incubation Time: 24 hours Result: Increased the level of MDR1 mRNA expression. |
Density | 1.25g/cm3 |
---|---|
Boiling Point | 444ºC at 760mmHg |
Melting Point | 90 - 92ºC |
Molecular Formula | C11H14N4O2 |
Molecular Weight | 234.25400 |
Flash Point | 222.3ºC |
Exact Mass | 234.11200 |
PSA | 62.06000 |
LogP | 1.29630 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.601 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H312-H315-H319-H332-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R20/21/22;R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | UV9290000 |
HS Code | 2933990090 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |